The population of older adults living with dementia is expected to swell to nearly 14 million by 2050 and is estimated to cost the US economy more than 500 billion each year. In the absence of a cure for Alzheimer's disease, the primary cause of dementia, there's interest in understanding modifiable risk factors. In theory, getting a handle on the modifiable risk factors for dementia, would enable public health efforts to reduce cognitive decline in dementia at the population level. We've come a long way in understanding the risk factors for Alzheimer's disease and other related dementias. However, there's still work to be done. In this episode, we'll speak with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.

Michigan Medicine research shows that a few key barriers stop young people from getting the glasses they need.   

Answers about the treatment of age-related macular degeneration, otherwise known as dry AMD, from a Michigan Medicine ophthalmologist.

For complex cataract surgery, Medicare reimbursements are far lower than a simpler form of the surgery.

What do you do when you know there’s a disease that’s as common as all cancers combined that steals a person’s vision? For Rajesh Rao, M.D., you conduct a groundbreaking first-in-human trial, with the goal of using an adult stem cell-based approach to restore vision. 

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in people over 50. An $11.5 million gift to the University of Michigan Health W.K. Kellogg Eye Center aims to change that.

Diabetes can damage your eyes and could lead to permanent vision loss without treatment. A U-M ophthalmologist shares four crucial things to know about diabetes and your eyes.

An analysis finds a “one size fits all” approach to prescribing opioids after surgery poses risks for addiction in certain patients.

A meta-analysis finds that vision impairment and blindness are tied to an increased risk of mortality, prompting the need to address global eye health disparities.

COVID-19 has been found in eyes and tears of infected patients, and now in the corneas of deceased donors. A new study highlights the importance of a donor screening process for Sars-CoV-2.

Three researchers say eye care accessibility around the globe isn’t keeping up with an aging population, posing challenges for eye care professionals over the next 30 years.

Michigan Medicine ophthalmologists create a scalable algorithm for triaging appointments during the pandemic

Innovative device ensures doctors obtain adequate fluid samples from the eye, helping with diagnosis and individualized treatment plans for patients.

University of Michigan research shows the direct correlation between systemic racism and racial health disparities in the United States.

Rare Disease Day is celebrated across the globe to raise awareness about rare diseases and how they impact patients’ lives. Michigan Medicine is working to better understand the mechanisms behind these rare diseases.